About this trial
The purpose of this study is to compare the effect of prasugrel plus low-dose aspirin versus high dose aspirin alone (300mg) and versus low dose aspirin alone (75 mg) in patients with chronic coronary disease undergoing coronary artery bypass grafting.
Eligibility criteria
Qualifiers
Age >18 years
Primary isolated CABG patients with stable coronary artery disease (chronic coronary syndrome) planned for at least 2 grafts. Coronary artery disease will be defined as a stenosis ≥ 70% based on coronary angiography, a FFR value ≤ 0.80 or iFr value ≤0.89; a left main diameter stenosis ≥ 50%, left main IVUS MLA value ≤ 6 mm2, or equivalent OCT measurements will also be considered.
Ability to comply with all study procedures and follow-up procedures
Signed Informed Consent to participate in the study.
Disqualifiers
Cardiogenic shock
Patients with recent acute coronary syndrome (ACS) (<12 months)
Single vessel CABG
Patients with preoperative atrial fibrillation
Trial design
Treatments tested in this trial
- High-Dose Aspirin 300 mg
- DAPT (Low-Dose Aspirin 75 mg + Prasugrel 10 mg)
- Low-Dose Aspirin 75 mg
Treatment groups
Sponsors and collaborators
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.
Lead sponsor
Medical Research Agency, Poland
Collaborator